| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 63.331 | 91.191 | 127.425 | 144.460 | 203.208 | 218.163 | 244.933 | 233.590 | 186.501 | 256.765 |
| Total Income - EUR | 69.614 | 93.409 | 130.664 | 145.191 | 203.398 | 219.435 | 251.893 | 239.999 | 201.706 | 263.216 |
| Total Expenses - EUR | 58.752 | 68.846 | 106.708 | 116.158 | 164.338 | 205.790 | 191.414 | 180.937 | 149.509 | 187.381 |
| Gross Profit/Loss - EUR | 10.862 | 24.563 | 23.956 | 29.033 | 39.060 | 13.644 | 60.479 | 59.061 | 52.197 | 75.835 |
| Net Profit/Loss - EUR | 8.896 | 21.827 | 22.148 | 27.588 | 37.007 | 11.652 | 58.037 | 56.669 | 50.332 | 67.943 |
| Employees | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Biovente Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 321 | 318 | 0 | 0 | 27.829 | 17.707 | 0 | 2.946 | 7.827 | 11.866 |
| Current Assets | 61.520 | 49.483 | 66.192 | 72.692 | 86.336 | 80.469 | 137.566 | 149.110 | 212.668 | 168.702 |
| Inventories | 16.660 | 25.616 | 33.576 | 25.214 | 49.264 | 13.407 | 64.061 | 71.735 | 111.749 | 66.769 |
| Receivables | 7.699 | 6.396 | 10.123 | 7.489 | 11.203 | 7.049 | 17.946 | 16.806 | 8.229 | 5.475 |
| Cash | 37.161 | 17.470 | 22.493 | 39.988 | 25.869 | 60.013 | 55.559 | 60.569 | 92.689 | 96.457 |
| Shareholders Funds | 4.455 | 21.881 | 43.659 | 62.077 | 76.809 | 79.971 | 116.444 | 134.197 | 143.245 | 167.451 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 57.386 | 27.920 | 22.534 | 10.615 | 37.521 | 18.206 | 21.122 | 17.859 | 77.250 | 13.116 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4639
|
|||||||||
Comments - Biovente Srl